The aim of this study was to evaluate the effects of nutraceuticals containing multiple supplemental facts (Virherbe®/Rekupros®) on sexual satisfaction and lower urinary tract symptoms (LUTS) in young–old men. In an open-label trial, 40 males (mean age 66 ± 13) with sexual disturbances and mild LUTS but without cognitive/motor impairment and clinical hypogonadism were enrolled. Sexual desire (SD; IIEF-SD domain) and satisfaction (Global Assessment Question; GAQ), the capacity to perform daily activities (evaluated by 6-min walking test [6MWT]), and International Prostate Symptoms Scores (IPSS) were evaluated before and after oral administration of 2 capsules/day of each supplement for 8 weeks. The difference from baseline for SD was +2.6 (p <.05) and −4.2 points for IPSS (p <.05), with significance in subscales of urinary streaming/nocturia (p <.01), respectively; 6MWT increased from 507 ± 44 versus 527 ± 58 meters (p <.001). GAQ scale-responses showed overall improvement in overall 75% population, with a significant improvement in QoL (p <.01). These changes returned to baseline at 1-month withdrawal follow-up. No adverse events were reported. These supplemental facts improved sexual desire, satisfaction with sex life, physical performance, and LUTS in young–old men, suggesting that they may be effective in patients in whom standard treatments are not suitable.

Effects of nutraceuticals on sexual satisfaction and lower urinary tract symptoms in a cohort of young–old men

Perri A.;
2018

Abstract

The aim of this study was to evaluate the effects of nutraceuticals containing multiple supplemental facts (Virherbe®/Rekupros®) on sexual satisfaction and lower urinary tract symptoms (LUTS) in young–old men. In an open-label trial, 40 males (mean age 66 ± 13) with sexual disturbances and mild LUTS but without cognitive/motor impairment and clinical hypogonadism were enrolled. Sexual desire (SD; IIEF-SD domain) and satisfaction (Global Assessment Question; GAQ), the capacity to perform daily activities (evaluated by 6-min walking test [6MWT]), and International Prostate Symptoms Scores (IPSS) were evaluated before and after oral administration of 2 capsules/day of each supplement for 8 weeks. The difference from baseline for SD was +2.6 (p <.05) and −4.2 points for IPSS (p <.05), with significance in subscales of urinary streaming/nocturia (p <.01), respectively; 6MWT increased from 507 ± 44 versus 527 ± 58 meters (p <.001). GAQ scale-responses showed overall improvement in overall 75% population, with a significant improvement in QoL (p <.01). These changes returned to baseline at 1-month withdrawal follow-up. No adverse events were reported. These supplemental facts improved sexual desire, satisfaction with sex life, physical performance, and LUTS in young–old men, suggesting that they may be effective in patients in whom standard treatments are not suitable.
aging
antioxidants
distress
erection
sexual desire
supplements
Aged
Cohort Studies
Dietary Supplements
Humans
Libido
Lower Urinary Tract Symptoms
Male
Orgasm
Prospective Studies
Quality of Life
Sexual Behavior
Treatment Outcome
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11770/307153
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact